Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
(2021) In Cell 184(1). p.11-75- Abstract
 Global dispersal and increasing frequency of the SARS-CoV-2 spike protein variant D614G are suggestive of a selective advantage but may also be due to a random founder effect. We investigate the hypothesis for positive selection of spike D614G in the United Kingdom using more than 25,000 whole genome SARS-CoV-2 sequences. Despite the availability of a large dataset, well represented by both spike 614 variants, not all approaches showed a conclusive signal of positive selection. Population genetic analysis indicates that 614G increases in frequency relative to 614D in a manner consistent with a selective advantage. We do not find any indication that patients infected with the spike 614G variant have higher COVID-19 mortality or clinical... (More)
Global dispersal and increasing frequency of the SARS-CoV-2 spike protein variant D614G are suggestive of a selective advantage but may also be due to a random founder effect. We investigate the hypothesis for positive selection of spike D614G in the United Kingdom using more than 25,000 whole genome SARS-CoV-2 sequences. Despite the availability of a large dataset, well represented by both spike 614 variants, not all approaches showed a conclusive signal of positive selection. Population genetic analysis indicates that 614G increases in frequency relative to 614D in a manner consistent with a selective advantage. We do not find any indication that patients infected with the spike 614G variant have higher COVID-19 mortality or clinical severity, but 614G is associated with higher viral load and younger age of patients. Significant differences in growth and size of 614G phylogenetic clusters indicate a need for continued study of this variant.
(Less)
- author
 - contributor
 - Balcazar Lopez, Carlos Enrique LU
 - author collaboration
 - organization
 - publishing date
 - 2021-01-07
 - type
 - Contribution to journal
 - publication status
 - published
 - subject
 - keywords
 - Amino Acid Substitution, Aspartic Acid/analysis, COVID-19/epidemiology, Genome, Viral, Glycine/analysis, Humans, Mutation, SARS-CoV-2/genetics, Spike Glycoprotein, Coronavirus/genetics, United Kingdom/epidemiology, Virulence, Whole Genome Sequencing
 - in
 - Cell
 - volume
 - 184
 - issue
 - 1
 - pages
 - 11 - 75
 - publisher
 - Cell Press
 - external identifiers
 - 
                
- pmid:33275900
 - scopus:85098925617
 
 - ISSN
 - 1097-4172
 - DOI
 - 10.1016/j.cell.2020.11.020
 - language
 - English
 - LU publication?
 - yes
 - id
 - b6d57e41-d7fc-4a42-9915-4a40c17f4522
 - date added to LUP
 - 2021-04-11 20:07:51
 - date last changed
 - 2025-11-03 07:47:25
 
@article{b6d57e41-d7fc-4a42-9915-4a40c17f4522,
  abstract     = {{<p>Global dispersal and increasing frequency of the SARS-CoV-2 spike protein variant D614G are suggestive of a selective advantage but may also be due to a random founder effect. We investigate the hypothesis for positive selection of spike D614G in the United Kingdom using more than 25,000 whole genome SARS-CoV-2 sequences. Despite the availability of a large dataset, well represented by both spike 614 variants, not all approaches showed a conclusive signal of positive selection. Population genetic analysis indicates that 614G increases in frequency relative to 614D in a manner consistent with a selective advantage. We do not find any indication that patients infected with the spike 614G variant have higher COVID-19 mortality or clinical severity, but 614G is associated with higher viral load and younger age of patients. Significant differences in growth and size of 614G phylogenetic clusters indicate a need for continued study of this variant.</p>}},
  author       = {{Volz, Erik and Hill, Verity and McCrone, John T and Price, Anna and Jorgensen, David and O'Toole, Áine and Southgate, Joel and Johnson, Robert and Jackson, Ben and Nascimento, Fabricia F and Rey, Sara M and Nicholls, Samuel M and Colquhoun, Rachel M and da Silva Filipe, Ana and Shepherd, James and Pascall, David J and Shah, Rajiv and Jesudason, Natasha and Li, Kathy and Jarrett, Ruth and Pacchiarini, Nicole and Bull, Matthew and Geidelberg, Lily and Siveroni, Igor and Goodfellow, Ian and Loman, Nicholas J and Pybus, Oliver G and Robertson, David L and Thomson, Emma C and Rambaut, Andrew and Connor, Thomas R}},
  issn         = {{1097-4172}},
  keywords     = {{Amino Acid Substitution; Aspartic Acid/analysis; COVID-19/epidemiology; Genome, Viral; Glycine/analysis; Humans; Mutation; SARS-CoV-2/genetics; Spike Glycoprotein, Coronavirus/genetics; United Kingdom/epidemiology; Virulence; Whole Genome Sequencing}},
  language     = {{eng}},
  month        = {{01}},
  number       = {{1}},
  pages        = {{11--75}},
  publisher    = {{Cell Press}},
  series       = {{Cell}},
  title        = {{Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity}},
  url          = {{http://dx.doi.org/10.1016/j.cell.2020.11.020}},
  doi          = {{10.1016/j.cell.2020.11.020}},
  volume       = {{184}},
  year         = {{2021}},
}